title: Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection.
abstract: Primary hepatic lymphoma (PHL) is a very rare sub-type of non-Hodgkin's lymphoma and hepatitis C infection may be a contributory factor. The association of hepatitis C infection and PHL causes difficulties in management since safety of rituximab in such situations is unclear due to lack of evidence. The role of anti-viral therapy in combination with chemotherapy is also uncertain. We describe the diagnostic and therapeutic challenges posed by a patient who was diagnosed with PHL and concurrent hepatitis C infection.
authors.affiliation: Haematology Department, Launceston General Hospital, Launceston, TAS Australia ; Launceston Clinical School, University of Tasmania, Launceston, TAS Australia.
authors.forename: Muhajir
authors.initials: M
authors.lastname: Mohamed
authors.affiliation: Pathology Department, Launceston General Hospital, Launceston, TAS Australia.
authors.forename: Ruchira
authors.initials: R
authors.lastname: Fernando
keywords: Hepatitis C; Primary hepatic lymphoma